Sources | Names Used |
---|---|
GDSC1000 | KIN001-260 |
PharmacoGx | KIN001-260 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TAB2 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.05 |
mRNA | FUNDC2 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.05 |
mRNA | CISD3 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.05 |
mRNA | ZXDC | GDSC1000 | pan-cancer | AAC | 0.062 | 0.05 |
mRNA | TEX33 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.05 |
mRNA | RNF123 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.05 |
mRNA | SUSD1 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.05 |
mRNA | CRACR2B | GDSC1000 | pan-cancer | AAC | 0.066 | 0.05 |
mRNA | SF3B1 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.05 |
mRNA | ARID3B | GDSC1000 | pan-cancer | AAC | 0.067 | 0.05 |